The Wall Street Journal reports that Genomic Health has developed the Oncotype DX colon-cancer test, a genetic screen "that can predict whether patients treated for early-stage colon cancer are likely to suffer a recurrence of the disease," according to the story. A validation study of the test was presented in advance of the American Society of Clinical Oncology annual meeting.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.